Cheryl Eckard went to the FDA after witnessing severe quality control violations at GlaxoSmithKline's Cidra plant in Puerto Rico, and was paid $96 million for her efforts.
Having trouble viewing this video? Try downloading the latest version of Flash or contact your IT department.
If you have a video that you think we should run, send a link to [email protected].
